Search

everythinglearnresearchcommunity

for

Search:↓

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Global collaboration in dermatology improved data sharing and patient care during COVID-19.

Cepharanthine shows promise as a COVID-19 treatment.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

More social media use during COVID-19 increased interest in cosmetic procedures.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Teletrichoscopy is a promising method for diagnosing hair disorders remotely during the COVID-19 pandemic.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Racial minorities faced more Covid-19 blame due to anti-fatness and structural racism.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

AGA might indicate higher risk for severe COVID-19.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

The pandemic changed the types of skin conditions seen, not the number of visits.

Some early COVID-19 mutations in patients predicted future common virus mutations.

Remote monitoring of chronic diseases like dermatomyositis is challenging and needs better tools for early detection and patient education.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

PCOS women with COVID-19 have higher cardiometabolic risks.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

A post-COVID-19 patient in Manaus developed cryptococcal meningitis, highlighting the need for better health education and sanitation.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

Public interest in hair loss increased during the COVID-19 pandemic.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.